Consistent to our data, PGD2 has been shown to be increased in the plasma of patients with SLE, and it amplified lupus-like disease and contributed to auto-antibody mediated kidney damage through CXCR4 (22). The gene discussed is CXCR4; the disease is systemic lupus erythematosus.